Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Safety Study of LY2811376 Single Doses in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions
- Status
- COMPLETED
- Phase
- PHASE2
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study
- Status
- TERMINATED
- Phase
- PHASE2
Memantine and Validation of a New Alzheimer's Disease Scale
- Status
- COMPLETED
- Phase
- PHASE3
Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
- Status
- COMPLETED
- Phase
- PHASE2